Latest Related Publications

GAP-f pDTG Implementation Considerations for National Programmes

In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 mg scored, dispersible tablets, also known as paediatric DTG (pDTG). Rapid introduction and rollout of pDTG is a priority to implement the World Health Organization (WHO) guidelines and ensure that children living with HIV receive the best […]

13 June 2022